Citius Pharmaceuticals (CTXR) Set To Hit New Highs: How to Trade Now?

The pharmaceutical sector has thrown up plenty of gems in recent times and naturally, investors are almost always on the lookout for stocks in the sector.

freestocks org 126848 unsplash

One of the stocks that recorded significant gains on Tuesday was that of the specialty pharmaceutical company Citius Pharmaceuticals Inc (NASDAQ: CTXR). The Citius stock surged by as high as 24% yesterday after the company issued a corporate update through a letter to its shareholders. It could be worthwhile for investors to take a look at what the company had to say.

The company revealed that the important interim analysts of the product Mino-Lok and review from the Data Monitoring Committee are expected at some point in the second quarter. On the other hand, Mino-Wrap is currently in pre-clinical development. However, the company expects that it is going to be able to apply for an IND to the FDA at some point towards the end of 2021. These are highly important updates and the excitement among investors is understandable.

Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.

Richard McEntire has 1844 posts and counting. See all posts by Richard McEntire